Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sabine Basler"'
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 2324 (2019)
Switzerland is aiming to eliminate measles, in line with the objectives of the World Health Organization (WHO). Physicians, laboratories and public health authorities have made great efforts to reach this goal. A continually increasing measles vaccin
Externí odkaz:
https://doaj.org/article/cdb6f5440cf846bcaccaadb36d4b3bc1
Publikováno v:
Swiss Medical Weekly, Vol 148, Iss 1920 (2018)
With an estimated antibody prevalence of 0.7% in the low-risk population, hepatitis C virus (HCV) endemicity in Switzerland is low. We reviewed data from mandatory hepatitis C surveillance for 1988–2015 in order to describe the evolution of acute H
Externí odkaz:
https://doaj.org/article/bf7e69d22984434a8a3ccf971e4bda28
Publikováno v:
Swiss Medical Weekly, Vol 147, Iss 0708 (2017)
With a hepatitis B prevalence of 0.3%, Switzerland is a country with low endemicity. Unlike most other countries, Switzerland’s recommendation for vaccination against hepatitis B has since 1998 focused on adolescents aged 11 to 15 years rather than
Externí odkaz:
https://doaj.org/article/ae22a9789c5e4906bfba38d28c30485c
Autor:
Gisela C. Getaz-Jimenez Velasco, Gesuele Renzi, Vladimir Lazarevic, Sabine Basler, Rita Born, Luke William Anson, Stefano Leo, Abdessalam Cherkaoui, Nadia Gaïa, Jacques Schrenzel, Myriam Girard
Publikováno v:
Journal of Infection, Vol. 79, No 3 (2019) pp. 277-287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac904bb0b987cde290c74fc1db062d06
https://doi.org/10.1016/j.jinf.2019.05.014
https://doi.org/10.1016/j.jinf.2019.05.014
Publikováno v:
Swiss medical weekly. 149
Switzerland is aiming to eliminate measles, in line with the objectives of the World Health Organization (WHO). Physicians, laboratories and public health authorities have made great efforts to reach this goal. A continually increasing measles vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad2e11f88d1e79c0a400258bb95befee
https://pubmed.ncbi.nlm.nih.gov/31185126
https://pubmed.ncbi.nlm.nih.gov/31185126
Publikováno v:
Swiss medical weekly. 148
With an estimated antibody prevalence of 0.7% in the low-risk population, hepatitis C virus (HCV) endemicity in Switzerland is low. We reviewed data from mandatory hepatitis C surveillance for 1988-2015 in order to describe the evolution of acute HCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c762480dfc8849c1f1a487eb6d63486
https://pubmed.ncbi.nlm.nih.gov/29698546
https://pubmed.ncbi.nlm.nih.gov/29698546
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f992f344410976c5044727fc7f8ca807
https://doi.org/10.4414/smf.2017.03054
https://doi.org/10.4414/smf.2017.03054
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c117ab40328ee83aa8018fc809918442
https://doi.org/10.4414/fms.2017.03054
https://doi.org/10.4414/fms.2017.03054
Publikováno v:
Swiss Medical Weekly. 147
With a hepatitis B prevalence of 0.3%, Switzerland is a country with low endemicity. Unlike most other countries, Switzerland's recommendation for vaccination against hepatitis B has since 1998 focused on adolescents aged 11 to 15 years rather than o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8168b33907faf104045a52d2581457
https://doi.org/10.4414/smw.2017.14409
https://doi.org/10.4414/smw.2017.14409